METHOD OF SURGICAL RETINA SEPARATION TREATMENT

FIELD: medicine; ophthalmology. ^ SUBSTANCE: subtotal three-port vitrectomy is performed, epiretinal membranes are removed. Perfluoroctane sulfonate (PFOS) is injected into vitreal cavity, and endolaser retina coagulation is performed. Then eyeball is tilted towards sclerectomy orifice where work en...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KOSTINA NATALIJA EVGEN'EVNA, GORSHKOV IL'JA MIKHAJLOVICH, TAKHCHIDI KHRISTO PERIKLOVICH
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	BANDAGES, DRESSINGS OR ABSORBENT PADS DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS FILTERS IMPLANTABLE INTO BLOOD VESSELS FIRST-AID KITS FOMENTATION HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES PROSTHESES TREATMENT OR PROTECTION OF EYES OR EARS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine; ophthalmology. ^ SUBSTANCE: subtotal three-port vitrectomy is performed, epiretinal membranes are removed. Perfluoroctane sulfonate (PFOS) is injected into vitreal cavity, and endolaser retina coagulation is performed. Then eyeball is tilted towards sclerectomy orifice where work end of cannula for heavy silicon oil injection is entered. Heavy silicon oil injection commences with preservation of eyeball tilt until complete removal of physiological solution from space between PFOS surface and crystalline lens diaphragm through opposite sclerectomy orifice. Further PFOS is replaced with silicon oil. ^ EFFECT: reduced retina separation relapse risk due to total tamponade of vitreal cavity by heavy silicon oil. ^ 2 ex